Related Experiment Videos
Predictive in silico modeling for hERG channel blockers.
1Vertex Pharmaceuticals Inc., 130 Waverly St., Cambridge, MA 02139-4242, USA. alex_aronov@vrtx.com
Drug Discovery Today
|February 19, 2005
Summary
Sudden death from non-antiarrhythmic drugs blocking the hERG channel is a growing concern. This review covers recent computational methods for predicting hERG channel interactions and drug safety.
Area of Science:
- Pharmacology and Toxicology
- Computational Chemistry
- Cardiovascular Drug Safety
Background:
- Increased regulatory scrutiny surrounds hERG channel-mediated sudden death linked to non-antiarrhythmic medications.
- The hERG channel's unique, hydrophobic binding site facilitates interactions with diverse drug structures.
- Predicting hERG channel blockade is crucial for drug development and patient safety.
Purpose of the Study:
- To review and summarize recent advancements in in silico methods for predicting hERG channel blockade.
- To highlight approaches focused on virtual library filtering and understanding structure-activity relationships (SAR) of hERG-drug interactions.
Main Methods:
- Review of recent literature on computational toxicology and drug discovery.
- Analysis of in silico methodologies applied to predict hERG channel interactions.
- Examination of structure-activity relationship studies for hERG channel blockers.
Main Results:
- Several in silico approaches have been developed to predict hERG channel blockade.
- These methods vary in their application, from early virtual screening to detailed SAR analysis.
- The field is rapidly evolving with new computational strategies emerging.
Conclusions:
- In silico prediction of hERG channel blockade is a vital tool in modern drug safety assessment.
- Continued development of these computational methods is essential for mitigating risks associated with drug-induced cardiotoxicity.
- This review provides an overview of the latest efforts in this critical area of pharmaceutical research.